Amos Hedt’s Post

Explore FAPI-directed theranostics in cancer care with The Journal of Nuclear Medicine's new podcast! Moderator Ken Herrmann and panelists delve into FAP history, challenges, and the road to clinical success. https://ow.ly/xjez50QuynT #JNuclMed #NuclearMedicine #FAPI #Theranostics

New JNM Podcast on the Future of FAPI Therapy Nouzha WiNMI leader,Group Expert of WiN Global EANM _WE Vp #WiNGlobal,#WiNMI,#WiN for peace,#WiN YG,#WiN Africa,#WiN IAEA,#WiN France,#WiN Europe,#AMMN ,#SNMMI,#PSNM,#AI,#Nuclear Medicine,#Oncology,#Molecular Imaging,#Myocardial imaging,#ASCO,#EANM,#EANM_WE,#EANM_WE, #WARMTH, #alpha Therapy, #beta Nuclear Medicine therapyVp,#Oncidium,#ESMIT,#SFMN,#UCLA,#EJNMMI,#Americanoncologyinstitute,#Urology,#Prostate,#TNE,#WiA,#Gliomas,#Lymphomas,#Burkitt,#PRRT,#211At,#Neurology,#Alzheimer,#Thyroid cancer

Explore FAPI-directed theranostics in cancer care with The Journal of Nuclear Medicine's new podcast! Moderator Ken Herrmann and panelists delve into FAPI history, challenges, and the road to clinical success. https://ow.ly/jO1Y50QucWR #JNuclMed #NuclearMedicine #FAPI #Theranostics

Dr. Siti Maisarah, Consultant Nuclear Medicine Physician, explains how the cutting-edge Siemens Healthineers Biograph Vision 450 PET/CT can improve patient safety and offer exceptional clarity in cancer detection. #PrinceCourt #PrinceCourtMC #ClinicalExcellence #InnovationAndTechnology #ForYouForLife

What is theranostics, and why do some researchers think it's the future of cancer diagnosis and treatment? In SNMMI's first feature on Jobs of Tomorrow, learn more about the groundbreaking field of nuclear medicine. View the whole episode, now on our Nuclear Medicine Careers website, here: https://lnkd.in/gr4W92r5 This episode features SNMMI member Carlos Uribe--full ambassador spotlight to come, so stay tuned! #nuclearmedicine #theranostics #cancerresearch #career #careergoals

Nuclear medicine experts from all over Europe gather these days at the EANM (European Association of Nuclear Medicine) Congress. Our team is also present to engage with leading experts, dive into groundbreaking research and discuss the future of nuclear medicine.  Part of that future is radioligand therapy. ✨ At Novartis, we are dedicated to reimagining cancer treatment through this type of innovative treatments that can give people living with cancer a better and longer life with their loved ones. To improve the access to radioligand therapy, we are working together with multiple stakeholders – healthcare professionals, hospitals, research institutes, patient organisations and more – on implementing the recently launched Belgian RLT action plan. 🚀 #EANM2024 #ReimagineMedicine #NovartisTogether #RadioligandTherapy

Is LNT here to stay? In a recent publication titled "Facilitating the End of the Linear No-Threshold Model Era" in the Journal of Nuclear Medicine, Professor Mohan Doss criticized the linear no-threshold (LNT) model. This model claims that any level of ionizing radiation increases the risk of cancer. Since the 1950s, LNT has formed the basis of global radiation protection policies. In his article, Doss states that despite continued endorsements, an increasing body of evidence challenges the LNT model. Instead, it suggests that low-level radiation exposure might reduce cancer risk, a concept known as radiation hormesis. https://lnkd.in/eGUwZgSR [Image generated by DALL-E (OpenAI) on June 27 2024] #LNT #Cancer #Dose #RadiationProtection

Nuclear Fun Fact : Nuclear medicine and radiation therapy are two ways nuclear technologies are used to treat cancer. In nuclear medicine, radioactive substances are introduced into the body to target and destroy cancer cells. Radiation therapy, on the other hand, uses high-energy radiation to shrink or eliminate tumors. Both approaches aim to selectively target and damage cancer cells while minimizing harm to healthy tissues.

Nuclear Fun Fact : Nuclear medicine and radiation therapy are two ways nuclear technologies are used to treat cancer. In nuclear medicine, radioactive substances are introduced into the body to target and destroy cancer cells. Radiation therapy, on the other hand, uses high-energy radiation to shrink or eliminate tumors. Both approaches aim to selectively target and damage cancer cells while minimizing harm to healthy tissues.

An excellent summation and especially important citing of the works looking into “how low can you go?” With respect to #ga68 #dotatate, as it has such broad implications for optimization outside of package insert of 0.054 mCi/kg (2 MBq/kg) #EANM2024 European Association of Nuclear Medicine (EANM) #nuclearmedicine